Atara Biotherapeutics, Inc. Common Stock (ATRA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. ATRA:NASDAQ GS Stock Quote - Atara Biotherapeutics Inc ... Stock analysis for Atara Biotherapeutics Inc (ATRA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Atara Biotherapeutics - ATRA - Stock Price & News | The ... atra $7.87 -$0.64 -7.5% Price as of April 1, 2020, 2:06 p.m. EDT View Interactive ATRA Charts ATRA | Atara Biotherapeutics Inc. Stock Price & News - WSJ
Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures.
Nov 08, 2019 · ATRA, Atara Biotherapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Atara Biotherapeutics Stock Quote: ATRA Stock News, Quotes, Analysis | Investors.com ATRA | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for ATARA BIOTHERAPEUTICS INC (ATRA), including profile, stock chart, recent news and events, analyst opinions, and research reports. ATRA Stock Price and Chart — NASDAQ:ATRA — TradingView View live ATARA BIOTHERAPEUTICS INC chart to track its stock's price action. Find market predictions, ATRA financials and market news.
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Recent Clinical, Operational and Strategic Progress. SOUTH SAN FRANCISCO, Calif., Feb. 27, 2020 -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel.
$ATRA in Uptrend: price expected to rise as it breaks its lower Bollinger Band on March 16, 2020. View odds for thi… https://t.co/RfJVRkSuM6. April 3rd 2020, 18 Jul 2019 (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, The aggregate market value of common stock held by non-affiliates of the Registrant, based on the closing sales price for such stock on June 29, 2018 as Atara Biotherapeutics Inc (ATRA) View SEC Filings from ATRA instead. crash hasn't yet reached levels associated with previous stock market bottoms. access and tools to invest like a Wall Street money manager – at a Main Street price. 21 Feb 2020 Stocks: Bioxcel Therapeutics (BTAI), Atara Biotherapeutics (ATRA) also reiterated a Buy rating on the stock with a $30.00 price target.